Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
ratio decreased » rate decreased (Expand Search)
Showing 2,181 - 2,200 results of 21,342 for search '(( significant ((ratio decreased) OR (greater decrease)) ) OR ( significant decrease decrease ))', query time: 0.59s Refine Results
  1. 2181
    The demographical and clinical characteristics of subjects at baseline.

    The demographical and clinical characteristics of subjects at baseline. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  2. 2182
    CONSORT flowchart.

    CONSORT flowchart. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  3. 2183
    Inpatient utilization of anticoagulants from 2019 to 2023.

    Inpatient utilization of anticoagulants from 2019 to 2023. by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 2184
    Indications for warfarin prescription in outpatients and inpatients in 2023.

    Indications for warfarin prescription in outpatients and inpatients in 2023. by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 2185
    Time to stabilization in the mediolateral direction.

    Time to stabilization in the mediolateral direction. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  6. 2186
    Western blotting for OMP expression using olfactory bulb and olfactory epithelium.

    Western blotting for OMP expression using olfactory bulb and olfactory epithelium. by Myeongguk Jeong (16386165)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 2187
    Outpatient utilization of anticoagulants from 2019 to 2023.

    Outpatient utilization of anticoagulants from 2019 to 2023. by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 2188
    Participant’s data including characteristics and primary outcome measurement.

    Participant’s data including characteristics and primary outcome measurement. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 2189
    Olfactory function test graphical summary and results.

    Olfactory function test graphical summary and results. by Myeongguk Jeong (16386165)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 2190
    Time to stabilization in the vertical direction.

    Time to stabilization in the vertical direction. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 2191
    DDC for four anticoagulants from 2019 to 2023.

    DDC for four anticoagulants from 2019 to 2023. by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 2192
    Utilization of anticoagulants from 2019 to 2023.

    Utilization of anticoagulants from 2019 to 2023. by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 2193
    The description of games.

    The description of games. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  14. 2194
    The expenditure on anticoagulants in the period of 2019-2023(million CNY).

    The expenditure on anticoagulants in the period of 2019-2023(million CNY). by Wei Luo (80175)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 2195
    Immunohistochemical staining results for OMP in olfactory bulb.

    Immunohistochemical staining results for OMP in olfactory bulb. by Myeongguk Jeong (16386165)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 2196
    The description of balance training.

    The description of balance training. by Sadaf Sepasgozar Sarkhosh (20436143)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 2197
    Effect of O-ag modifying glycosyltransferases on complement activation and <i>Salmonella</i> interactions with human serum.

    Effect of O-ag modifying glycosyltransferases on complement activation and <i>Salmonella</i> interactions with human serum. by Fermin E. Guerra (6084545)

    Published 2025
    “…<p>(A) O-ag modifications by glycosyltransferases in <i>S.</i> Paratyphi A decrease complement activation as measured by C5a release and (B) IgM binding. …”
    Save to List
    Saved in:
  18. 2198
    O-ag length and composition impacts complement activation by <i>Salmonella</i> nontyphoidal and enteric fever serovars.

    O-ag length and composition impacts complement activation by <i>Salmonella</i> nontyphoidal and enteric fever serovars. by Fermin E. Guerra (6084545)

    Published 2025
    Save to List
    Saved in:
  19. 2199
    <i>rfbV</i> gene triplication in S. Paratyphi A increases VL O-ag production and reduces C3b deposition.

    <i>rfbV</i> gene triplication in S. Paratyphi A increases VL O-ag production and reduces C3b deposition. by Fermin E. Guerra (6084545)

    Published 2025
    “…Increased VL O-ag production in <i>S.</i> Typhimurium decreases C3b binding, whereas L O-ag promotes C3b binding. …”
    Save to List
    Saved in:
  20. 2200
    <i>S</i>. Paratyphi A has deficient L O-ag production due to R98C mutation in WzzB.

    <i>S</i>. Paratyphi A has deficient L O-ag production due to R98C mutation in WzzB. by Fermin E. Guerra (6084545)

    Published 2025
    Save to List
    Saved in:

Search Tools: